Despite a recent 45% rally, I maintain a 'Sell' view on CVS due to its underwhelming execution record and rising leverage ...

In the latest executive shakeup at CVS, the pharmacy giant has named a new president of its pharmacy benefit management ...

The high cost of sickle cell gene therapies is pushing private insurers and Medicaid programs to develop new payment models.

After underperforming throughout 2024, shares of CVS Health (NYSE: CVS) are surging. From the end of 2024 through Feb. 14, ...

We recently compiled a list of the 10 Best Performing S&P 500 Stocks So Far in 2025. In this article, we are going to take a ...

StockNews.com upgraded shares of CVS Health (NYSE:CVS – Free Report) from a sell rating to a hold rating in a report issued on Thursday morning. Several other brokerages have also issued reports on ...

HARTFORD-- This week, the CEO of CVS Health expressed confidence that the company would turn around its embattled health-insurance business, the Hartford- based Aetna. "People used to refer to Aetna ...

Humana (HUM) won't be alone in cutting back on its Medicare Advantage offerings. Other insurers, including CVS (CVS) and Centene (CNC), have also warned that they are cutting back on lower-profit or ...

Millions of people fall ill with the flu every year, and adults age 65 and older are at higher risk of developing serious ...

CVS Health has eliminated more than 1,000 jobs based at or reporting to its offices in Hartford, which include the ...

CVS Health (NYSE:CVS – Free Report) had its price objective decreased by UBS Group from $62.00 to $59.00 in a research note ...